SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 119 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 7.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $832,944 | -31.4% | 215,231 | +5.6% | 0.00% | -100.0% |
| Q2 2023 | $1,214,839 | +84.0% | 203,832 | +1.0% | 0.00% | – |
| Q1 2023 | $660,229 | -15.0% | 201,905 | -0.7% | 0.00% | – |
| Q4 2022 | $776,805 | -4.9% | 203,316 | +41.6% | 0.00% | -100.0% |
| Q3 2022 | $816,997 | -10.0% | 143,574 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $908,241 | -7.0% | 144,213 | +20.9% | 0.00% | 0.0% |
| Q1 2022 | $976,475 | +37.0% | 119,296 | +160.8% | 0.00% | – |
| Q4 2021 | $713,000 | -30.3% | 45,735 | +0.7% | 0.00% | -100.0% |
| Q3 2021 | $1,023,000 | +198.3% | 45,415 | +160.5% | 0.00% | – |
| Q2 2021 | $343,000 | – | 17,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |